Pharming (PHAR) Enterprise Value (2019 - 2025)
Historic Enterprise Value for Pharming (PHAR) over the last 7 years, with Q3 2025 value amounting to -$132.7 million.
- Pharming's Enterprise Value changed N/A to -$132.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$132.7 million, marking a year-over-year change of. This contributed to the annual value of -$54.9 million for FY2024, which is 1100.89% up from last year.
- Per Pharming's latest filing, its Enterprise Value stood at -$132.7 million for Q3 2025.
- In the past 5 years, Pharming's Enterprise Value registered a high of -$193714.3 during Q4 2021, and its lowest value of -$212.2 billion during Q1 2021.
- Over the past 5 years, Pharming's median Enterprise Value value was -$184.8 million (recorded in 2023), while the average stood at -$23.7 billion.
- Data for Pharming's Enterprise Value shows a peak YoY increase of 9991.06% (in 2022) and a maximum YoY decrease of 10693492.1% (in 2022) over the last 5 years.
- Pharming's Enterprise Value (Quarter) stood at -$193714.3 in 2021, then crashed by 106934.92% to -$207.3 million in 2022, then skyrocketed by 70.22% to -$61.7 million in 2023, then increased by 11.01% to -$54.9 million in 2024, then crashed by 141.49% to -$132.7 million in 2025.
- Its last three reported values are -$132.7 million in Q3 2025, -$92.4 million for Q2 2025, and -$58.8 million during Q1 2025.